Macrobid

[Nitrofurantoin]

REFERENCES:

1. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically --Third Edition. Approved Standard NCCLS Document M7-A3, Vol. 13, No. 25, NCCLS, Villanova, PA, December 1993.

2. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests --Fifth Edition. Approved Standard NCCLS Document M2-A5, Vol. 13, No. 24, NCCLS, Villanova, PA, December 1993.

Text Continues Below

---

Macrobid (nitrofurantoin monohydrate/ macrocrystals)
Procter & Gamble Pharmaceuticals 11 Revised March 2003

CLINICAL STUDIES:

Controlled clinical trials comparing Macrobid 100 mg p. o. q12h and Macrodantin 50 mg p. o. q6h in the treatment of acute uncomplicated urinary tract infections demonstrated approximately 75% microbiologic eradication of susceptible pathogens in each treatment group.

Mfg. By: OSG Norwich Pharmaceuticals, Inc.
North Norwich, NY 13814
Dist. by: Procter & Gamble Pharmaceuticals,
TM Owner, Cincinnati, OH 45202

REVISED March 2003

Page:  << Prev | 1 | 2